BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17147926)

  • 1. Aldosterone breakthrough from a pharmacological perspective.
    Alfie J
    Hypertens Res; 2023 May; 46(5):1350. PubMed ID: 36810620
    [No Abstract]   [Full Text] [Related]  

  • 2. Adrenal G Protein-Coupled Receptors and the Failing Heart: A Long-distance, Yet Intimate Affair.
    Borges JI; Ferraino KE; Cora N; Nagliya D; Suster MS; Carbone AM; Lymperopoulos A
    J Cardiovasc Pharmacol; 2022 Sep; 80(3):386-392. PubMed ID: 34983911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone breakthrough as a clue to the physiological importance of paracrine regulation of aldosterone secretion.
    Lopez AG; Louiset E; Lefebvre H
    Hypertens Res; 2022 Nov; 45(11):1832-1834. PubMed ID: 36028626
    [No Abstract]   [Full Text] [Related]  

  • 4. Global cardiovascular protection in chronic kidney disease.
    Ruiz-Hurtado G; Sarafidis P; Fernández-Alfonso MS; Waeber B; Ruilope LM
    Nat Rev Cardiol; 2016 Oct; 13(10):603-8. PubMed ID: 27053454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series).
    Maron BA; Leopold JA
    Pulm Circ; 2014 Jun; 4(2):200-10. PubMed ID: 25006439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aliskiren reduces home blood pressure and albuminuria in patients with hypertensive nephrosclerosis.
    Suzuki H; Okada K; Abe M; Maruyama N; Yoshida Y; Baba S; Takashima H; Soma M
    Clin Exp Nephrol; 2013 Jun; 17(3):386-95. PubMed ID: 23135868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of aldosterone synthesis and secretion by ca(2+) channel antagonists.
    Ikeda K; Isaka T; Fujioka K; Manome Y; Tojo K
    Int J Endocrinol; 2012; 2012():519467. PubMed ID: 23097668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of blood pressure and salt homeostasis by endothelin.
    Kohan DE; Rossi NF; Inscho EW; Pollock DM
    Physiol Rev; 2011 Jan; 91(1):1-77. PubMed ID: 21248162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RAAS in the pathogenesis and treatment of diabetic nephropathy.
    Ruggenenti P; Cravedi P; Remuzzi G
    Nat Rev Nephrol; 2010 Jun; 6(6):319-30. PubMed ID: 20440277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 stimulates aldosterone synthesis in Conn's adenomas via both A and B receptors coupled with the protein kinase C- and cyclooxygenase-dependent signaling pathways.
    Rossi GP; Andreis PG; Neri G; Tortorella C; Pelizzo MR; Sacchetto A; Nussdorfer GG
    J Investig Med; 2000 Sep; 48(5):343-50. PubMed ID: 10979239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that both ETA and ETB receptor subtypes are involved in the in vivo aldosterone secretagogue effect of endothelin-1 in rats.
    Mazzocchi G; Rebuffat P; Gottardo G; Meneghelli V; Nussdorfer GG
    Res Exp Med (Berl); 1996; 196(3):145-52. PubMed ID: 8875700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone breakthrough during RAS blockade: a role for endothelins and their antagonists?
    Rossi GP
    Curr Hypertens Rep; 2006 Jun; 8(3):262-8. PubMed ID: 17147926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endothelin-aldosterone axis and cardiovascular diseases.
    Rossi GP; Cavallin M; Nussdorfer GG; Pessina AC
    J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S49-52. PubMed ID: 11811378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
    Athyros VG; Mikhailidis DP; Kakafika AI; Tziomalos K; Karagiannis A
    Expert Opin Pharmacother; 2007 Apr; 8(5):529-35. PubMed ID: 17376010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between endothelin-1 and the renin-angiotensin-aldosterone system.
    Rossi GP; Sacchetto A; Cesari M; Pessina AC
    Cardiovasc Res; 1999 Aug; 43(2):300-7. PubMed ID: 10536660
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.